About Central Maine Medical Center
The Central Maine Medical Center is a hospital located at 300 Main Street in the city of Lewiston, Maine. It serves most of Androscoggin County, including Lewiston and Auburn, Maine and various small and medium-sized communities. It is designated as a trauma center.
There are 250 beds in Central Maine Medical Center.
Clinical Trials at Central Maine Medical Center
During the past decade, Central Maine Medical Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 21 clinical trials were completed, i.e. on
average, 123.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 13 clinical trials were completed. i.e. 162.5%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Central Maine Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 9 trials, followed by "National Cancer Institute (NCI)" with 7 trials
sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "SWOG Cancer Research Network"
with 4 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Central Maine Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Central Maine Medical Center
According to Clinical.Site data, the most researched conditions in "Central Maine Medical Center" are
"Breast Cancer" (7 trials), "Breast Adenocarcinoma" (3 trials), "Musculoskeletal Complications" (2 trials), "Neoplasm Metastasis" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Central Maine Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Central Maine Medical Center
Most popular intervention types in "Central Maine Medical Center" are "Drug" (37 trials), "Other" (19 trials), "Radiation" (11 trials), "Biological" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Placebo" (9 trials), "Quality-of-Life Assessment" (5 trials), "Paclitaxel" (4 trials) and "Abemaciclib" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Central Maine Medical Center
The vast majority of trials in "Central Maine Medical Center" are
35 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Central Maine Medical Center
Currently, there are NaN active trials in "Central Maine Medical Center".
undefined are not yet recruiting,
8 are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Central Maine Medical Center,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Central Maine Medical Center, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Central Maine Medical Center
Central Maine Medical Center has several departments that took part in Clinical trials: "Central Maine Comprehensive Cancer Center at Central Maine Medical Center" - 11 trials, "Central Maine Pulmonary Associates" - 3 trials, "Central Maine Heart & Vascular Institute" - 2 trials